The FDA and complex generic sponsors are looking for more opportunities to discuss scientific questions and potentially streamline the assessment process. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
